Most Read
    Image 01 Image 02 Image 03

    FDA Approves Emergency Use of Remdesivir to Treat Wuhan Coronavirus Patients

    FDA Approves Emergency Use of Remdesivir to Treat Wuhan Coronavirus Patients

    Dr. Anthony Fauci said on Wednesday that a study found that “1,063 patients tested with Remdesivir took 11 days to recover versus 15 days for others.”

    FDA issued an emergency use authorization to allow doctors to use Remdesivir to treat patients suffering from the Wuhan coronavirus.

    Remdesivir, an experimental antiviral drug from Gilead Science, showed promise against the coronavirus in a clinical study.

    Dr. Anthony Fauci said on Wednesday that a study found that “1,063 patients tested with Remdesivir took 11 days to recover versus 15 days for others.”

    From the FDA:

    “FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step forward in battling COVID-19 and another example of the Trump Administration moving as quickly as possible to use science to save lives,” said HHS Secretary Alex Azar. “NIH, FDA, and scientists across America and around the world have worked tirelessly with patients to get us this new potential treatment for COVID-19. The seamless cooperation between government and private industry under the President’s all-of-America approach to COVID-19 is getting treatment options to patients in record time.”

    The emergency use authorization allows for remdesivir to be distributed in the U.S. and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. Severe disease is defined as patients with low blood oxygen levels or needing oxygen therapy or more intensive breathing support such as a mechanical ventilator.

    “From day one, the FDA has been committed to expediting the development and availability of potential COVID-19 treatments. Today’s action is an important step in our efforts to collaborate with innovators and researchers to provide sick patients timely access to new therapies where appropriate, while at the same time supporting research to further evaluate whether they are safe and effective,” said FDA Commissioner Stephen M. Hahn, M.D. “There’s tremendous interest among all parties to identify and arm ourselves with medicines to combat COVID-19, and through our Coronavirus Treatment Acceleration Program, the FDA is working around-the-clock and using every tool at our disposal to speed these efforts.”


    Donations tax deductible
    to the full extent allowed by law.


    ronk | May 1, 2020 at 7:18 pm

    notice they did not use hydro quinine in another group

    I do not trust that guy for nothing.

    redc1c4 | May 1, 2020 at 8:10 pm

    i wonder how much stock in the parent company his wife owns?

    pushing the expensive drug over the cheap one we KNOW w&rks in a few days…

    something smells here.

    i wonder what the side effect profile is like on this stuff?

    rightway | May 1, 2020 at 9:10 pm

    I suspect the Hydroxychloroquine studies will be discontinued. So,we will never know. Curious how a fully randomized double blinds study for Remdisavir was completed quickly. Especially interesting that we could establish its safety compared to a decades old FDA drug. Something doesn’t add up.

      MarkS in reply to rightway. | May 2, 2020 at 7:35 am

      Where Fauci is involved, it never does! He’s the guy who in March said to take a cruise, and in April that it was OK to have sex with a stranger found on the Tinder website, but that it was much too dangerous to get a haircut

    BierceAmbrose | May 2, 2020 at 1:43 pm


    I thought currently used anti-virals were another insane fantasy polluting the brain of Orange Man Bad?

    Now do UV treatments n sanatizing lavage? Maybe nebulizers or gaseous delivery?

    While we’re at it, what about the other drug … either the docs reporting their “anecdotal” results are lying, or that one looks more promising than Rem-whatever. Let’s do a controlled study?

      BierceAmbrose in reply to BierceAmbrose. | May 2, 2020 at 1:46 pm

      “Emergency” … anybody who is sick onto death is having an emergency. Why can’t we get anything that might help to people who are in extremis?

      The FDA is confused: their job isn’t to keep treatments from getting to people, it’s *to get treatments to people safely.*

      — Their operations measure isn’t how much they’ve said “no”, it’s how much they’ve said “yes” safely.

      — Their success measure is more life, health, adventure *becuase of* interventions delivered out to the population (that’s us(.


    Leave a Comment

    Leave a Reply

    You must be logged in to post a comment.

    Notify me of followup comments via e-mail (or subscribe without commenting.)

    Font Resize
    Contrast Mode
    Send this to a friend